Implementation of pharmaceutical care: Important aspects for a lasting service

Luanna Gabriella Resende da  Silva; Thays Santos  Mendonça; Paulo Roque  Obreli-Neto; Mariana Linhares  Pereira; André Oliveira  Baldoni

doi:10.1590/

Authors

Luanna Gabriella Resende da Silva Programa de Pós-Graduação em Ciências da Saúde, Federal University of São João del Rei (UFSJ), campus Centro-Oeste dona Lindu (CCO), Divinópolis, Minas Gerais, Brasil https://orcid.org/0000-0003-1879-5166
Thays Santos Mendonça Programa de Pós-Graduação em Ciências da Saúde, Federal University of São João del Rei (UFSJ), campus Centro-Oeste dona Lindu (CCO), Divinópolis, Minas Gerais, Brasil https://orcid.org/0000-0002-7005-8780
Paulo Roque Obreli-Neto Departamento de Farmácia, Centro Universitário das Universidades Integradas de Ourinhos (UniFIO), Ourinhos, São Paulo, Brasil https://orcid.org/0000-0003-3749-9426
Mariana Linhares Pereira Programa de Pós-Graduação em Ciências Farmacêuticas, Federal University of São João del Rei (UFSJ), campus Centro-Oeste dona Lindu (CCO), Divinópolis, Minas Gerais, Brasil https://orcid.org/0000-0002-3214-2789
André Oliveira Baldoni Programa de Pós-Graduação em Ciências da Saúde, Federal University of São João del Rei (UFSJ), campus Centro-Oeste dona Lindu (CCO), Divinópolis, Minas Gerais, Brasil https://orcid.org/0000-0001-6379-0415

DOI:

https://doi.org/10.1590/

Keywords:

Health Systems, Pharmaceutical care, Pharmaceutical Services

Abstract

This is a commentary manuscript, which aims to carry out a critical analysis of the effects of Pharmaceutical Care (PC) without the continuity of the service by healthcare professionals. PC has proven to be a very effective practice for improving pharmacotherapy for medicine users. In Brazil, it is noticeable that in the vast majority of cases, PC is carried out by professionals who are already working within the healthcare systems under the supervision of researchers affiliated with universities, for the purpose of research and data collection. When the research ends there is no continuation of the service, which hinders its continuous implementation and the establishment of a connection with the community. It was observed that after discharge from pharmacotherapeutic monitoring, due to the interruption of the service, there was a deterioration in the clinical and laboratory parameters of individuals with chronic diseases. Therefore, it is clear that PC needs to be implemented not only for research purposes, but also in the “real world”, so that it is long-lasting and permanent with the monitoring of the patients using medication.

Downloads

References

Apikoglu S, Selcuk A, Ozcan V, Balta E, Turker M, Albayrak OD, et al. The first nationwide implementation of pharmaceutical care practices through a continuing professional development approach for community pharmacists. Int J Clin Pharm. 2022 Dec 14; 44(6): 1223-31.

Aquino JA, Souza TN, Sanches C, Pereira ML, Baldoni AO. What is the effectiveness of post-discharge pharmacotherapeutic empowerment of patients with diabetes? Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2019 Mar; 13(2): 1321-3.

Carrapato P, Correia P, Garcia B. Determinante da saúde no Brasil: a procura da equidade na saúde. Saúde soc. 2017; 26(3): 676-689.

Cazarim M de S, de Freitas O, Penaforte TR, Achcar A, Pereira LRL. Impact Assessment of Pharmaceutical Care in the Management of Hypertension and Coronary Risk Factors after Discharge. PLoS One. 2016 Jun 15; 11(6): e0155204.

Coradi A, Figueiredo F, Adami F, Fonseca F, Souto R. Effectiveness on diabetes mellitus treatment through apharmaceutical care in a government program foraccess to medicine: a randomised controlled trial. JAPHAC. 2020; 1(7): 237-49.

da Silva LGR, da Silva Pinto AW, de Queiroz WE, Coelho CC, Blatt CR, Oliveira MG, et al. Deprescribing clonazepam in primary care older patients: a feasibility study. Int J Clin Pharm. 2022 Apr 13; 44(2): 489-98.

Dewulf NLS, dos Santos V, Leira Pereira LR, Troncon LEA. The invisible pharmacist. Am J Pharm Educ. 2009 Jul 10; 73(4): 74.

Foucault-Fruchard L, Bizzoto L, Allemang-Trivalle A, Renoult-Pierre P, Antier D. Compared benefits of educational programs dedicated to diabetic patients with or without community pharmacist involvement. Prim Health Care Res Dev. 2020 Nov 6; 21: e49.

Franco M da CS, Jesus FM, Abreu CR de C. Papel do farmacêutico no controle glicêmico do paciente diabético. Revista JRG de Estudos Acadêmicos. 2020; 3(7): 636-45.

Garcia-Cardenas V, Rossing C, Benrimoj SI. Pharmaceutical Care and Implementation Strategies. In: The Pharmacist Guide to Implementing Pharmaceutical Care. Cham: Springer International Publishing; 2019. p. 203-12.

Gemmeke M, Koster ES, Rodijk EA, Taxis K, Bouvy ML. Community pharmacists’ perceptions on providing fall prevention services: a mixed-methods study. Int J Clin Pharm. 2021 Dec 13; 43(6): 1533-45.

Hohl CM, Partovi N, Ghement I, Wickham ME, McGrail K, Reddekopp LN, et al. Impact of early in-hospital medication review by clinical pharmacists on health services utilization. PLoS One. 2017 Feb 13; 12(2): e0170495.

Ilardo ML, Speciale A. The Community Pharmacist: Perceived Barriers and Patient-Centered Care Communication. Int J Environ Res Public Health. 2020 Jan 15; 17(2): 536.

Lum ZK, Siaw MYL, Lee MJX, Koh Z, Zhang PQ, Eng SK, et al. Impact of pharmaceutical care on mental well-being and perceived health among community-dwelling individuals with type 2 diabetes. Quality of Life Research. 2019 Dec 29; 28(12): 3273-9.

Marques PA, Simão TA, Moriya MM, Dias G, Antunes VM de S, Oliveira CR. Prescrição farmacêutica de medicamentos fitoterápicos. Braz J Nat Sci. 2019 Jan 11; 2(1): 15.

Mendonça TS, Oliveira WN, Belo VS, Silva ES, Pereira ML, Obreli-Neto PR, et al. Clinical and humanistic impact of pharmacotherapeutic follow-up in patients with type 1 diabetes mellitus treated judicially. Diabetol Metab Syndr. 2022 Dec 3; 14(1): 61.

Obreli-Neto PR, Marusic S, De Lyra Júnior DP, Pilger D, Cruciol-Souza JM, Gaeti WP, et al. Effect of a 36-month Pharmaceutical Care Program on the Coronary Heart Disease Risk in Elderly Diabetic and Hypertensive Patients. J Pharm Pharm Sci. 2011 Jun 24; 14(2): 249.

Pereira LB, Guidoni CM, Borges AP de S, Pereira LRL. Avaliação da efetividade do acompanhamento farmacoterapêutico no controle do diabetes mellitus tipo 2 em longo prazo. Clinical & Biomedical Research. 2018; 38(3): 237-44.

Posses CP, Lima EM de, Brasil GA, Cassaro KO dos S, Cruz MM, Rezende AMB, et al. Resultados clínicos e humanísticos em pacientes dislipidêmicos atendidos em farmácia pública antes e após a implantação do Cuidado Farmacêutico. Res Soc Dev. 2022 Jun 13; 11(8): e14411830610.

Waltering I, Schwalbe O, Hempel G. Identification of factors for a successful implementation of medication reviews in community pharmacies: Using Positive Deviance in pharmaceutical care. Int J Clin Pharm. 2022 Feb 6; 44(1): 79-89.

Wang W, Geng L, Sun C, Li H, Wang J. Efficacy of Pharmaceutical Care in Patients with Type 2 Diabetes Mellitus and Hypertension: A Randomized Controlled Trial. Int J Clin Pract. 2022 Mar 24; 2022: 1-6.

Implementation of pharmaceutical care

Important aspects for a lasting service

Authors

DOI:

Keywords:

Abstract

Downloads

References

Downloads

Published

Issue

Section

License

How to Cite

Funding data